nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—ABCB1—Lisinopril—systemic scleroderma	0.0713	0.267	CbGbCtD
Bepridil—ABCB1—Captopril—systemic scleroderma	0.0534	0.2	CbGbCtD
Bepridil—CYP2D6—Captopril—systemic scleroderma	0.0503	0.188	CbGbCtD
Bepridil—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.042	0.157	CbGbCtD
Bepridil—ABCB1—Prednisone—systemic scleroderma	0.0336	0.126	CbGbCtD
Bepridil—ABCB1—Methotrexate—systemic scleroderma	0.0169	0.063	CbGbCtD
Bepridil—TNNC1—connective tissue—systemic scleroderma	0.0078	0.0509	CbGeAlD
Bepridil—CALM2—artery—systemic scleroderma	0.00668	0.0436	CbGeAlD
Bepridil—CALM1—artery—systemic scleroderma	0.00665	0.0434	CbGeAlD
Bepridil—PDE1A—smooth muscle tissue—systemic scleroderma	0.00624	0.0407	CbGeAlD
Bepridil—CALM2—endothelium—systemic scleroderma	0.00564	0.0368	CbGeAlD
Bepridil—CALM1—endothelium—systemic scleroderma	0.00562	0.0366	CbGeAlD
Bepridil—TNNC1—tendon—systemic scleroderma	0.00536	0.035	CbGeAlD
Bepridil—CALM2—blood vessel—systemic scleroderma	0.00521	0.0339	CbGeAlD
Bepridil—CALM1—blood vessel—systemic scleroderma	0.00518	0.0338	CbGeAlD
Bepridil—CACNA1H—smooth muscle tissue—systemic scleroderma	0.00487	0.0318	CbGeAlD
Bepridil—TNNC1—lung—systemic scleroderma	0.00471	0.0307	CbGeAlD
Bepridil—PDE1A—tendon—systemic scleroderma	0.00469	0.0306	CbGeAlD
Bepridil—KCNQ1—digestive system—systemic scleroderma	0.00458	0.0299	CbGeAlD
Bepridil—PDE1A—lung—systemic scleroderma	0.00411	0.0268	CbGeAlD
Bepridil—CACNA1C—connective tissue—systemic scleroderma	0.00406	0.0265	CbGeAlD
Bepridil—CACNA2D2—lung—systemic scleroderma	0.00396	0.0258	CbGeAlD
Bepridil—KCNQ1—lung—systemic scleroderma	0.00383	0.0249	CbGeAlD
Bepridil—CACNA1C—smooth muscle tissue—systemic scleroderma	0.00371	0.0242	CbGeAlD
Bepridil—CALM3—smooth muscle tissue—systemic scleroderma	0.00311	0.0203	CbGeAlD
Bepridil—ATP1A1—connective tissue—systemic scleroderma	0.00303	0.0198	CbGeAlD
Bepridil—CACNA1C—digestive system—systemic scleroderma	0.00293	0.0191	CbGeAlD
Bepridil—ATP1A1—smooth muscle tissue—systemic scleroderma	0.00277	0.0181	CbGeAlD
Bepridil—ATP1A1—skin of body—systemic scleroderma	0.00274	0.0178	CbGeAlD
Bepridil—CALM2—connective tissue—systemic scleroderma	0.00267	0.0174	CbGeAlD
Bepridil—CALM1—connective tissue—systemic scleroderma	0.00266	0.0173	CbGeAlD
Bepridil—CACNA1D—lung—systemic scleroderma	0.00265	0.0173	CbGeAlD
Bepridil—CACNA1C—lung—systemic scleroderma	0.00245	0.016	CbGeAlD
Bepridil—CALM2—smooth muscle tissue—systemic scleroderma	0.00244	0.0159	CbGeAlD
Bepridil—CALM1—smooth muscle tissue—systemic scleroderma	0.00243	0.0158	CbGeAlD
Bepridil—CALM2—skin of body—systemic scleroderma	0.00241	0.0157	CbGeAlD
Bepridil—CALM1—skin of body—systemic scleroderma	0.0024	0.0156	CbGeAlD
Bepridil—CALM3—tendon—systemic scleroderma	0.00234	0.0152	CbGeAlD
Bepridil—ATP1A1—digestive system—systemic scleroderma	0.00219	0.0143	CbGeAlD
Bepridil—ATP1A1—tendon—systemic scleroderma	0.00208	0.0136	CbGeAlD
Bepridil—ABCB1—blood vessel—systemic scleroderma	0.00207	0.0135	CbGeAlD
Bepridil—CALM3—lung—systemic scleroderma	0.00205	0.0134	CbGeAlD
Bepridil—CALM2—digestive system—systemic scleroderma	0.00193	0.0126	CbGeAlD
Bepridil—CALM1—digestive system—systemic scleroderma	0.00192	0.0125	CbGeAlD
Bepridil—CALM2—tendon—systemic scleroderma	0.00183	0.012	CbGeAlD
Bepridil—ATP1A1—lung—systemic scleroderma	0.00183	0.0119	CbGeAlD
Bepridil—CALM1—tendon—systemic scleroderma	0.00183	0.0119	CbGeAlD
Bepridil—CALM2—lung—systemic scleroderma	0.00161	0.0105	CbGeAlD
Bepridil—CALM1—lung—systemic scleroderma	0.0016	0.0105	CbGeAlD
Bepridil—Insomnia—Captopril—systemic scleroderma	0.00122	0.00264	CcSEcCtD
Bepridil—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00122	0.00264	CcSEcCtD
Bepridil—Tremor—Mycophenolic acid—systemic scleroderma	0.00122	0.00264	CcSEcCtD
Bepridil—Abdominal pain—Mometasone—systemic scleroderma	0.00122	0.00263	CcSEcCtD
Bepridil—Body temperature increased—Mometasone—systemic scleroderma	0.00122	0.00263	CcSEcCtD
Bepridil—Paraesthesia—Captopril—systemic scleroderma	0.00121	0.00263	CcSEcCtD
Bepridil—Palpitations—Leflunomide—systemic scleroderma	0.00121	0.00261	CcSEcCtD
Bepridil—Dyspnoea—Captopril—systemic scleroderma	0.00121	0.00261	CcSEcCtD
Bepridil—Arrhythmia—Lisinopril—systemic scleroderma	0.0012	0.0026	CcSEcCtD
Bepridil—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0026	CcSEcCtD
Bepridil—Somnolence—Captopril—systemic scleroderma	0.0012	0.0026	CcSEcCtD
Bepridil—Cough—Leflunomide—systemic scleroderma	0.00119	0.00258	CcSEcCtD
Bepridil—Dyspepsia—Captopril—systemic scleroderma	0.00119	0.00257	CcSEcCtD
Bepridil—Cardiac failure—Prednisone—systemic scleroderma	0.00119	0.00256	CcSEcCtD
Bepridil—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00256	CcSEcCtD
Bepridil—Dizziness—Pentoxifylline—systemic scleroderma	0.00118	0.00255	CcSEcCtD
Bepridil—Hypertension—Leflunomide—systemic scleroderma	0.00118	0.00255	CcSEcCtD
Bepridil—Decreased appetite—Captopril—systemic scleroderma	0.00118	0.00254	CcSEcCtD
Bepridil—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00253	CcSEcCtD
Bepridil—Vertigo—Mycophenolic acid—systemic scleroderma	0.00117	0.00253	CcSEcCtD
Bepridil—Syncope—Mycophenolic acid—systemic scleroderma	0.00117	0.00253	CcSEcCtD
Bepridil—Myalgia—Leflunomide—systemic scleroderma	0.00116	0.00251	CcSEcCtD
Bepridil—Anxiety—Leflunomide—systemic scleroderma	0.00116	0.0025	CcSEcCtD
Bepridil—Constipation—Captopril—systemic scleroderma	0.00116	0.0025	CcSEcCtD
Bepridil—Flatulence—Lisinopril—systemic scleroderma	0.00116	0.0025	CcSEcCtD
Bepridil—Tension—Lisinopril—systemic scleroderma	0.00115	0.00249	CcSEcCtD
Bepridil—Palpitations—Mycophenolic acid—systemic scleroderma	0.00115	0.00249	CcSEcCtD
Bepridil—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00115	0.00248	CcSEcCtD
Bepridil—Nervousness—Lisinopril—systemic scleroderma	0.00114	0.00246	CcSEcCtD
Bepridil—Dry mouth—Leflunomide—systemic scleroderma	0.00114	0.00246	CcSEcCtD
Bepridil—Cough—Mycophenolic acid—systemic scleroderma	0.00114	0.00246	CcSEcCtD
Bepridil—Rash—Pentoxifylline—systemic scleroderma	0.00113	0.00243	CcSEcCtD
Bepridil—Hypertension—Mycophenolic acid—systemic scleroderma	0.00112	0.00243	CcSEcCtD
Bepridil—Dermatitis—Pentoxifylline—systemic scleroderma	0.00112	0.00243	CcSEcCtD
Bepridil—Headache—Pentoxifylline—systemic scleroderma	0.00112	0.00242	CcSEcCtD
Bepridil—Myalgia—Mycophenolic acid—systemic scleroderma	0.00111	0.0024	CcSEcCtD
Bepridil—Vision blurred—Lisinopril—systemic scleroderma	0.00111	0.00239	CcSEcCtD
Bepridil—Gastrointestinal pain—Captopril—systemic scleroderma	0.00111	0.00239	CcSEcCtD
Bepridil—Anxiety—Mycophenolic acid—systemic scleroderma	0.00111	0.00239	CcSEcCtD
Bepridil—Asthenia—Mometasone—systemic scleroderma	0.0011	0.00239	CcSEcCtD
Bepridil—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00238	CcSEcCtD
Bepridil—Tremor—Lisinopril—systemic scleroderma	0.0011	0.00238	CcSEcCtD
Bepridil—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00237	CcSEcCtD
Bepridil—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00108	0.00235	CcSEcCtD
Bepridil—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00108	0.00233	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00108	0.00232	CcSEcCtD
Bepridil—Body temperature increased—Captopril—systemic scleroderma	0.00107	0.00231	CcSEcCtD
Bepridil—Abdominal pain—Captopril—systemic scleroderma	0.00107	0.00231	CcSEcCtD
Bepridil—CYP2D6—digestive system—systemic scleroderma	0.00106	0.00694	CbGeAlD
Bepridil—Oedema—Mycophenolic acid—systemic scleroderma	0.00106	0.0023	CcSEcCtD
Bepridil—Anorexia—Leflunomide—systemic scleroderma	0.00106	0.0023	CcSEcCtD
Bepridil—Nausea—Pentoxifylline—systemic scleroderma	0.00106	0.00229	CcSEcCtD
Bepridil—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00228	CcSEcCtD
Bepridil—Vertigo—Lisinopril—systemic scleroderma	0.00105	0.00228	CcSEcCtD
Bepridil—Diarrhoea—Mometasone—systemic scleroderma	0.00105	0.00228	CcSEcCtD
Bepridil—Syncope—Lisinopril—systemic scleroderma	0.00105	0.00228	CcSEcCtD
Bepridil—Shock—Mycophenolic acid—systemic scleroderma	0.00105	0.00226	CcSEcCtD
Bepridil—Palpitations—Lisinopril—systemic scleroderma	0.00104	0.00224	CcSEcCtD
Bepridil—Loss of consciousness—Lisinopril—systemic scleroderma	0.00103	0.00223	CcSEcCtD
Bepridil—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00103	0.00222	CcSEcCtD
Bepridil—Cough—Lisinopril—systemic scleroderma	0.00102	0.00221	CcSEcCtD
Bepridil—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00102	0.0022	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00102	0.0022	CcSEcCtD
Bepridil—Anorexia—Mycophenolic acid—systemic scleroderma	0.00101	0.00219	CcSEcCtD
Bepridil—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00219	CcSEcCtD
Bepridil—Tension—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00218	CcSEcCtD
Bepridil—Insomnia—Leflunomide—systemic scleroderma	0.00101	0.00218	CcSEcCtD
Bepridil—Paraesthesia—Leflunomide—systemic scleroderma	0.001	0.00216	CcSEcCtD
Bepridil—Myalgia—Lisinopril—systemic scleroderma	0.000999	0.00216	CcSEcCtD
Bepridil—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000999	0.00216	CcSEcCtD
Bepridil—Anxiety—Lisinopril—systemic scleroderma	0.000996	0.00215	CcSEcCtD
Bepridil—Dyspnoea—Leflunomide—systemic scleroderma	0.000994	0.00215	CcSEcCtD
Bepridil—Dyspepsia—Leflunomide—systemic scleroderma	0.000981	0.00212	CcSEcCtD
Bepridil—Dry mouth—Lisinopril—systemic scleroderma	0.000977	0.00211	CcSEcCtD
Bepridil—Rash—Mometasone—systemic scleroderma	0.000971	0.0021	CcSEcCtD
Bepridil—Asthenia—Captopril—systemic scleroderma	0.00097	0.0021	CcSEcCtD
Bepridil—Dermatitis—Mometasone—systemic scleroderma	0.00097	0.0021	CcSEcCtD
Bepridil—Decreased appetite—Leflunomide—systemic scleroderma	0.000969	0.00209	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000969	0.00209	CcSEcCtD
Bepridil—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000965	0.00209	CcSEcCtD
Bepridil—Headache—Mometasone—systemic scleroderma	0.000965	0.00209	CcSEcCtD
Bepridil—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000963	0.00208	CcSEcCtD
Bepridil—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000962	0.00208	CcSEcCtD
Bepridil—Insomnia—Mycophenolic acid—systemic scleroderma	0.000962	0.00208	CcSEcCtD
Bepridil—Oedema—Lisinopril—systemic scleroderma	0.000958	0.00207	CcSEcCtD
Bepridil—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000955	0.00206	CcSEcCtD
Bepridil—Constipation—Leflunomide—systemic scleroderma	0.000953	0.00206	CcSEcCtD
Bepridil—Pain—Leflunomide—systemic scleroderma	0.000953	0.00206	CcSEcCtD
Bepridil—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000948	0.00205	CcSEcCtD
Bepridil—Somnolence—Mycophenolic acid—systemic scleroderma	0.000945	0.00204	CcSEcCtD
Bepridil—Shock—Lisinopril—systemic scleroderma	0.000942	0.00204	CcSEcCtD
Bepridil—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000936	0.00202	CcSEcCtD
Bepridil—Abdominal pain—Azathioprine—systemic scleroderma	0.000933	0.00202	CcSEcCtD
Bepridil—Body temperature increased—Azathioprine—systemic scleroderma	0.000933	0.00202	CcSEcCtD
Bepridil—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000926	0.002	CcSEcCtD
Bepridil—Diarrhoea—Captopril—systemic scleroderma	0.000925	0.002	CcSEcCtD
Bepridil—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000924	0.002	CcSEcCtD
Bepridil—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000924	0.002	CcSEcCtD
Bepridil—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000922	0.00199	CcSEcCtD
Bepridil—Erectile dysfunction—Prednisone—systemic scleroderma	0.000921	0.00199	CcSEcCtD
Bepridil—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000918	0.00198	CcSEcCtD
Bepridil—Nausea—Mometasone—systemic scleroderma	0.000915	0.00198	CcSEcCtD
Bepridil—Anorexia—Lisinopril—systemic scleroderma	0.000913	0.00197	CcSEcCtD
Bepridil—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000912	0.00197	CcSEcCtD
Bepridil—Pain—Mycophenolic acid—systemic scleroderma	0.000909	0.00197	CcSEcCtD
Bepridil—Constipation—Mycophenolic acid—systemic scleroderma	0.000909	0.00197	CcSEcCtD
Bepridil—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000909	0.00196	CcSEcCtD
Bepridil—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000904	0.00195	CcSEcCtD
Bepridil—Cough—Mycophenolate mofetil—systemic scleroderma	0.000897	0.00194	CcSEcCtD
Bepridil—Dizziness—Captopril—systemic scleroderma	0.000894	0.00193	CcSEcCtD
Bepridil—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000893	0.00193	CcSEcCtD
Bepridil—Depression—Prednisone—systemic scleroderma	0.000889	0.00192	CcSEcCtD
Bepridil—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000888	0.00192	CcSEcCtD
Bepridil—Body temperature increased—Leflunomide—systemic scleroderma	0.000881	0.0019	CcSEcCtD
Bepridil—Abdominal pain—Leflunomide—systemic scleroderma	0.000881	0.0019	CcSEcCtD
Bepridil—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000875	0.00189	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000873	0.00189	CcSEcCtD
Bepridil—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000872	0.00189	CcSEcCtD
Bepridil—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00087	0.00188	CcSEcCtD
Bepridil—Insomnia—Lisinopril—systemic scleroderma	0.000866	0.00187	CcSEcCtD
Bepridil—Paraesthesia—Lisinopril—systemic scleroderma	0.00086	0.00186	CcSEcCtD
Bepridil—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000856	0.00185	CcSEcCtD
Bepridil—Dyspnoea—Lisinopril—systemic scleroderma	0.000854	0.00185	CcSEcCtD
Bepridil—Rash—Captopril—systemic scleroderma	0.000853	0.00184	CcSEcCtD
Bepridil—Dermatitis—Captopril—systemic scleroderma	0.000852	0.00184	CcSEcCtD
Bepridil—Somnolence—Lisinopril—systemic scleroderma	0.000852	0.00184	CcSEcCtD
Bepridil—Headache—Captopril—systemic scleroderma	0.000847	0.00183	CcSEcCtD
Bepridil—Dyspepsia—Lisinopril—systemic scleroderma	0.000843	0.00182	CcSEcCtD
Bepridil—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000841	0.00182	CcSEcCtD
Bepridil—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000841	0.00182	CcSEcCtD
Bepridil—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000839	0.00181	CcSEcCtD
Bepridil—Decreased appetite—Lisinopril—systemic scleroderma	0.000833	0.0018	CcSEcCtD
Bepridil—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000827	0.00179	CcSEcCtD
Bepridil—Shock—Mycophenolate mofetil—systemic scleroderma	0.000826	0.00178	CcSEcCtD
Bepridil—Constipation—Lisinopril—systemic scleroderma	0.000819	0.00177	CcSEcCtD
Bepridil—Pain—Lisinopril—systemic scleroderma	0.000819	0.00177	CcSEcCtD
Bepridil—Bradycardia—Prednisone—systemic scleroderma	0.000815	0.00176	CcSEcCtD
Bepridil—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000811	0.00175	CcSEcCtD
Bepridil—Diarrhoea—Azathioprine—systemic scleroderma	0.000808	0.00175	CcSEcCtD
Bepridil—Nausea—Captopril—systemic scleroderma	0.000803	0.00174	CcSEcCtD
Bepridil—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000801	0.00173	CcSEcCtD
Bepridil—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.0008	0.00173	CcSEcCtD
Bepridil—Asthenia—Leflunomide—systemic scleroderma	0.0008	0.00173	CcSEcCtD
Bepridil—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000783	0.00169	CcSEcCtD
Bepridil—Dizziness—Azathioprine—systemic scleroderma	0.000781	0.00169	CcSEcCtD
Bepridil—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00077	0.00166	CcSEcCtD
Bepridil—ABCB1—digestive system—systemic scleroderma	0.000766	0.005	CbGeAlD
Bepridil—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000765	0.00165	CcSEcCtD
Bepridil—Asthenia—Mycophenolic acid—systemic scleroderma	0.000763	0.00165	CcSEcCtD
Bepridil—Diarrhoea—Leflunomide—systemic scleroderma	0.000763	0.00165	CcSEcCtD
Bepridil—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000759	0.00164	CcSEcCtD
Bepridil—Body temperature increased—Lisinopril—systemic scleroderma	0.000757	0.00164	CcSEcCtD
Bepridil—Abdominal pain—Lisinopril—systemic scleroderma	0.000757	0.00164	CcSEcCtD
Bepridil—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000754	0.00163	CcSEcCtD
Bepridil—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000748	0.00162	CcSEcCtD
Bepridil—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000746	0.00161	CcSEcCtD
Bepridil—Drowsiness—Methotrexate—systemic scleroderma	0.000745	0.00161	CcSEcCtD
Bepridil—Rash—Azathioprine—systemic scleroderma	0.000744	0.00161	CcSEcCtD
Bepridil—Dermatitis—Azathioprine—systemic scleroderma	0.000744	0.00161	CcSEcCtD
Bepridil—Depression—Methotrexate—systemic scleroderma	0.000743	0.00161	CcSEcCtD
Bepridil—Headache—Azathioprine—systemic scleroderma	0.000739	0.0016	CcSEcCtD
Bepridil—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000739	0.0016	CcSEcCtD
Bepridil—Dizziness—Leflunomide—systemic scleroderma	0.000737	0.00159	CcSEcCtD
Bepridil—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00073	0.00158	CcSEcCtD
Bepridil—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000728	0.00157	CcSEcCtD
Bepridil—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000725	0.00157	CcSEcCtD
Bepridil—Pain—Mycophenolate mofetil—systemic scleroderma	0.000718	0.00155	CcSEcCtD
Bepridil—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000718	0.00155	CcSEcCtD
Bepridil—Arrhythmia—Prednisone—systemic scleroderma	0.000715	0.00155	CcSEcCtD
Bepridil—Sweating—Methotrexate—systemic scleroderma	0.000715	0.00154	CcSEcCtD
Bepridil—Dizziness—Mycophenolic acid—systemic scleroderma	0.000703	0.00152	CcSEcCtD
Bepridil—Rash—Leflunomide—systemic scleroderma	0.000703	0.00152	CcSEcCtD
Bepridil—Dermatitis—Leflunomide—systemic scleroderma	0.000702	0.00152	CcSEcCtD
Bepridil—Nausea—Azathioprine—systemic scleroderma	0.000701	0.00152	CcSEcCtD
Bepridil—Headache—Leflunomide—systemic scleroderma	0.000698	0.00151	CcSEcCtD
Bepridil—Asthenia—Lisinopril—systemic scleroderma	0.000687	0.00149	CcSEcCtD
Bepridil—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000686	0.00148	CcSEcCtD
Bepridil—Rash—Mycophenolic acid—systemic scleroderma	0.00067	0.00145	CcSEcCtD
Bepridil—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00067	0.00145	CcSEcCtD
Bepridil—Headache—Mycophenolic acid—systemic scleroderma	0.000666	0.00144	CcSEcCtD
Bepridil—Pharyngitis—Methotrexate—systemic scleroderma	0.000664	0.00144	CcSEcCtD
Bepridil—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000663	0.00143	CcSEcCtD
Bepridil—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000663	0.00143	CcSEcCtD
Bepridil—Nausea—Leflunomide—systemic scleroderma	0.000662	0.00143	CcSEcCtD
Bepridil—Vision blurred—Prednisone—systemic scleroderma	0.000657	0.00142	CcSEcCtD
Bepridil—Diarrhoea—Lisinopril—systemic scleroderma	0.000655	0.00142	CcSEcCtD
Bepridil—ABCB1—lung—systemic scleroderma	0.00064	0.00417	CbGeAlD
Bepridil—Dizziness—Lisinopril—systemic scleroderma	0.000633	0.00137	CcSEcCtD
Bepridil—Nausea—Mycophenolic acid—systemic scleroderma	0.000632	0.00137	CcSEcCtD
Bepridil—Vertigo—Prednisone—systemic scleroderma	0.000626	0.00135	CcSEcCtD
Bepridil—Syncope—Prednisone—systemic scleroderma	0.000625	0.00135	CcSEcCtD
Bepridil—Tinnitus—Methotrexate—systemic scleroderma	0.000624	0.00135	CcSEcCtD
Bepridil—Cardiac disorder—Methotrexate—systemic scleroderma	0.000621	0.00134	CcSEcCtD
Bepridil—Loss of consciousness—Prednisone—systemic scleroderma	0.000613	0.00132	CcSEcCtD
Bepridil—Rash—Lisinopril—systemic scleroderma	0.000604	0.00131	CcSEcCtD
Bepridil—Dermatitis—Lisinopril—systemic scleroderma	0.000603	0.0013	CcSEcCtD
Bepridil—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000602	0.0013	CcSEcCtD
Bepridil—Hypertension—Prednisone—systemic scleroderma	0.000602	0.0013	CcSEcCtD
Bepridil—Headache—Lisinopril—systemic scleroderma	0.0006	0.0013	CcSEcCtD
Bepridil—Myalgia—Prednisone—systemic scleroderma	0.000593	0.00128	CcSEcCtD
Bepridil—Anxiety—Prednisone—systemic scleroderma	0.000591	0.00128	CcSEcCtD
Bepridil—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000574	0.00124	CcSEcCtD
Bepridil—Nausea—Lisinopril—systemic scleroderma	0.000569	0.00123	CcSEcCtD
Bepridil—Oedema—Prednisone—systemic scleroderma	0.000569	0.00123	CcSEcCtD
Bepridil—Shock—Prednisone—systemic scleroderma	0.00056	0.00121	CcSEcCtD
Bepridil—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000555	0.0012	CcSEcCtD
Bepridil—Hyperhidrosis—Prednisone—systemic scleroderma	0.00055	0.00119	CcSEcCtD
Bepridil—Vision blurred—Methotrexate—systemic scleroderma	0.000549	0.00119	CcSEcCtD
Bepridil—Anorexia—Prednisone—systemic scleroderma	0.000542	0.00117	CcSEcCtD
Bepridil—Rash—Mycophenolate mofetil—systemic scleroderma	0.000529	0.00114	CcSEcCtD
Bepridil—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000529	0.00114	CcSEcCtD
Bepridil—Headache—Mycophenolate mofetil—systemic scleroderma	0.000526	0.00114	CcSEcCtD
Bepridil—Vertigo—Methotrexate—systemic scleroderma	0.000523	0.00113	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000518	0.00112	CcSEcCtD
Bepridil—Insomnia—Prednisone—systemic scleroderma	0.000515	0.00111	CcSEcCtD
Bepridil—Paraesthesia—Prednisone—systemic scleroderma	0.000511	0.0011	CcSEcCtD
Bepridil—Cough—Methotrexate—systemic scleroderma	0.000508	0.0011	CcSEcCtD
Bepridil—Dyspepsia—Prednisone—systemic scleroderma	0.000501	0.00108	CcSEcCtD
Bepridil—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000498	0.00108	CcSEcCtD
Bepridil—Myalgia—Methotrexate—systemic scleroderma	0.000496	0.00107	CcSEcCtD
Bepridil—Decreased appetite—Prednisone—systemic scleroderma	0.000495	0.00107	CcSEcCtD
Bepridil—Constipation—Prednisone—systemic scleroderma	0.000486	0.00105	CcSEcCtD
Bepridil—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000465	0.00101	CcSEcCtD
Bepridil—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00046	0.000994	CcSEcCtD
Bepridil—Anorexia—Methotrexate—systemic scleroderma	0.000453	0.00098	CcSEcCtD
Bepridil—Abdominal pain—Prednisone—systemic scleroderma	0.00045	0.000972	CcSEcCtD
Bepridil—Body temperature increased—Prednisone—systemic scleroderma	0.00045	0.000972	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000433	0.000936	CcSEcCtD
Bepridil—Insomnia—Methotrexate—systemic scleroderma	0.00043	0.00093	CcSEcCtD
Bepridil—Paraesthesia—Methotrexate—systemic scleroderma	0.000427	0.000923	CcSEcCtD
Bepridil—Dyspnoea—Methotrexate—systemic scleroderma	0.000424	0.000916	CcSEcCtD
Bepridil—Somnolence—Methotrexate—systemic scleroderma	0.000423	0.000914	CcSEcCtD
Bepridil—Dyspepsia—Methotrexate—systemic scleroderma	0.000418	0.000905	CcSEcCtD
Bepridil—Decreased appetite—Methotrexate—systemic scleroderma	0.000413	0.000893	CcSEcCtD
Bepridil—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00041	0.000887	CcSEcCtD
Bepridil—Asthenia—Prednisone—systemic scleroderma	0.000408	0.000882	CcSEcCtD
Bepridil—Pain—Methotrexate—systemic scleroderma	0.000407	0.000879	CcSEcCtD
Bepridil—Diarrhoea—Prednisone—systemic scleroderma	0.000389	0.000841	CcSEcCtD
Bepridil—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000389	0.00084	CcSEcCtD
Bepridil—Dizziness—Prednisone—systemic scleroderma	0.000376	0.000813	CcSEcCtD
Bepridil—Abdominal pain—Methotrexate—systemic scleroderma	0.000376	0.000812	CcSEcCtD
Bepridil—Body temperature increased—Methotrexate—systemic scleroderma	0.000376	0.000812	CcSEcCtD
Bepridil—Rash—Prednisone—systemic scleroderma	0.000359	0.000775	CcSEcCtD
Bepridil—Dermatitis—Prednisone—systemic scleroderma	0.000358	0.000775	CcSEcCtD
Bepridil—Headache—Prednisone—systemic scleroderma	0.000356	0.00077	CcSEcCtD
Bepridil—Asthenia—Methotrexate—systemic scleroderma	0.000341	0.000737	CcSEcCtD
Bepridil—Nausea—Prednisone—systemic scleroderma	0.000338	0.00073	CcSEcCtD
Bepridil—Diarrhoea—Methotrexate—systemic scleroderma	0.000325	0.000703	CcSEcCtD
Bepridil—Dizziness—Methotrexate—systemic scleroderma	0.000314	0.00068	CcSEcCtD
Bepridil—Rash—Methotrexate—systemic scleroderma	0.0003	0.000648	CcSEcCtD
Bepridil—Dermatitis—Methotrexate—systemic scleroderma	0.000299	0.000647	CcSEcCtD
Bepridil—Headache—Methotrexate—systemic scleroderma	0.000298	0.000644	CcSEcCtD
Bepridil—Nausea—Methotrexate—systemic scleroderma	0.000282	0.00061	CcSEcCtD
Bepridil—CALM1—Alzheimers Disease—IL1B—systemic scleroderma	0.000183	0.00157	CbGpPWpGaD
Bepridil—PDE1B—Disease—CSK—systemic scleroderma	0.00018	0.00154	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—SMAD7—systemic scleroderma	0.000178	0.00153	CbGpPWpGaD
Bepridil—PDE1B—Hemostasis—MMP1—systemic scleroderma	0.000175	0.0015	CbGpPWpGaD
Bepridil—CALM3—VEGFA-VEGFR2 Pathway—NOS3—systemic scleroderma	0.000174	0.00149	CbGpPWpGaD
Bepridil—CACNA1C—Axon guidance—MMP2—systemic scleroderma	0.000174	0.00149	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—SELP—systemic scleroderma	0.000173	0.00148	CbGpPWpGaD
Bepridil—PDE1B—Immune System—TNFAIP3—systemic scleroderma	0.000171	0.00147	CbGpPWpGaD
Bepridil—PDE1B—Immune System—BLK—systemic scleroderma	0.000169	0.00145	CbGpPWpGaD
Bepridil—PDE1B—Disease—CD247—systemic scleroderma	0.000169	0.00145	CbGpPWpGaD
Bepridil—CALM1—VEGFA-VEGFR2 Pathway—NOS3—systemic scleroderma	0.000168	0.00145	CbGpPWpGaD
Bepridil—CALM2—VEGFA-VEGFR2 Pathway—NOS3—systemic scleroderma	0.000168	0.00145	CbGpPWpGaD
Bepridil—CALM2—Endochondral Ossification—TGFB1—systemic scleroderma	0.000168	0.00144	CbGpPWpGaD
Bepridil—CALM1—Endochondral Ossification—TGFB1—systemic scleroderma	0.000168	0.00144	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—SELP—systemic scleroderma	0.000167	0.00144	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—SELP—systemic scleroderma	0.000167	0.00144	CbGpPWpGaD
Bepridil—CALM3—Signaling by VEGF—NOS3—systemic scleroderma	0.000164	0.00141	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—RHOB—systemic scleroderma	0.000161	0.00139	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—HSPG2—systemic scleroderma	0.000159	0.00137	CbGpPWpGaD
Bepridil—CALM1—Signaling by VEGF—NOS3—systemic scleroderma	0.000159	0.00136	CbGpPWpGaD
Bepridil—CALM2—Signaling by VEGF—NOS3—systemic scleroderma	0.000159	0.00136	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—RHOB—systemic scleroderma	0.000156	0.00134	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—RHOB—systemic scleroderma	0.000156	0.00134	CbGpPWpGaD
Bepridil—CACNA1H—Developmental Biology—MMP9—systemic scleroderma	0.000154	0.00132	CbGpPWpGaD
Bepridil—PDE1A—Immune System—CTLA4—systemic scleroderma	0.000152	0.0013	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—RHOB—systemic scleroderma	0.000151	0.0013	CbGpPWpGaD
Bepridil—CACNA1D—Axon guidance—MMP9—systemic scleroderma	0.000149	0.00128	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—CSK—systemic scleroderma	0.000147	0.00126	CbGpPWpGaD
Bepridil—CALM3—Platelet degranulation—TGFB1—systemic scleroderma	0.000145	0.00125	CbGpPWpGaD
Bepridil—PDE1A—GPCR downstream signaling—EDN1—systemic scleroderma	0.000144	0.00123	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	0.000143	0.00123	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—HSPG2—systemic scleroderma	0.000142	0.00122	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—CSK—systemic scleroderma	0.000142	0.00122	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—CSK—systemic scleroderma	0.000142	0.00122	CbGpPWpGaD
Bepridil—CACNA1D—Developmental Biology—MMP2—systemic scleroderma	0.000141	0.00121	CbGpPWpGaD
Bepridil—CALM2—Platelet degranulation—TGFB1—systemic scleroderma	0.000141	0.00121	CbGpPWpGaD
Bepridil—CALM1—Platelet degranulation—TGFB1—systemic scleroderma	0.000141	0.00121	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—HSPG2—systemic scleroderma	0.00014	0.0012	CbGpPWpGaD
Bepridil—PDE1B—Immune System—CTLA4—systemic scleroderma	0.000139	0.00119	CbGpPWpGaD
Bepridil—PDE1A—Hemostasis—NOS3—systemic scleroderma	0.000139	0.00119	CbGpPWpGaD
Bepridil—CALM3—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.000138	0.00119	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—ITGAM—systemic scleroderma	0.000138	0.00119	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—RHOB—systemic scleroderma	0.000138	0.00118	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CSK—systemic scleroderma	0.000137	0.00118	CbGpPWpGaD
Bepridil—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	0.000135	0.00116	CbGpPWpGaD
Bepridil—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	0.000135	0.00116	CbGpPWpGaD
Bepridil—CALM2—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.000134	0.00115	CbGpPWpGaD
Bepridil—CALM1—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic scleroderma	0.000134	0.00115	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—ITGAM—systemic scleroderma	0.000134	0.00115	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—ITGAM—systemic scleroderma	0.000134	0.00115	CbGpPWpGaD
Bepridil—PDE1B—GPCR downstream signaling—EDN1—systemic scleroderma	0.000131	0.00113	CbGpPWpGaD
Bepridil—CACNA1C—Axon guidance—MMP9—systemic scleroderma	0.000131	0.00112	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—EDN1—systemic scleroderma	0.00013	0.00112	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—HSPG2—systemic scleroderma	0.00013	0.00112	CbGpPWpGaD
Bepridil—CALM3—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	0.000129	0.00111	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CSK—systemic scleroderma	0.000127	0.00109	CbGpPWpGaD
Bepridil—CACNA1H—Developmental Biology—TGFB1—systemic scleroderma	0.000127	0.00109	CbGpPWpGaD
Bepridil—PDE1B—Hemostasis—NOS3—systemic scleroderma	0.000127	0.00109	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CSK—systemic scleroderma	0.000126	0.00108	CbGpPWpGaD
Bepridil—CALM2—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	0.000125	0.00107	CbGpPWpGaD
Bepridil—CALM1—Myometrial Relaxation and Contraction Pathways—NOS3—systemic scleroderma	0.000125	0.00107	CbGpPWpGaD
Bepridil—PDE1A—Immune System—HLA-DQB1—systemic scleroderma	0.000125	0.00107	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—ITGAM—systemic scleroderma	0.000124	0.00107	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—CD247—systemic scleroderma	0.000124	0.00107	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—MMP2—systemic scleroderma	0.000124	0.00106	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CSK—systemic scleroderma	0.000123	0.00106	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CSK—systemic scleroderma	0.000123	0.00106	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—CTGF—systemic scleroderma	0.000121	0.00104	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—ITGAM—systemic scleroderma	0.00012	0.00103	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—CD247—systemic scleroderma	0.00012	0.00103	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—CD247—systemic scleroderma	0.00012	0.00103	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—ITGAM—systemic scleroderma	0.00012	0.00103	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CD247—systemic scleroderma	0.00012	0.00103	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—EDN1—systemic scleroderma	0.000119	0.00102	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IL1A—systemic scleroderma	0.000119	0.00102	CbGpPWpGaD
Bepridil—PDE1A—Immune System—CD40LG—systemic scleroderma	0.000118	0.00101	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—TNFAIP3—systemic scleroderma	0.000117	0.001	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CD247—systemic scleroderma	0.000116	0.000992	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CD247—systemic scleroderma	0.000116	0.000992	CbGpPWpGaD
Bepridil—PDE1B—Immune System—HLA-DQB1—systemic scleroderma	0.000114	0.000979	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—TNFAIP3—systemic scleroderma	0.000113	0.000968	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—TNFAIP3—systemic scleroderma	0.000113	0.000968	CbGpPWpGaD
Bepridil—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	0.000111	0.000954	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—BLK—systemic scleroderma	0.000111	0.000949	CbGpPWpGaD
Bepridil—CALM3—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	0.00011	0.000945	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL1A—systemic scleroderma	0.000108	0.00093	CbGpPWpGaD
Bepridil—PDE1B—Immune System—CD40LG—systemic scleroderma	0.000108	0.000925	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—BLK—systemic scleroderma	0.000107	0.000918	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—BLK—systemic scleroderma	0.000107	0.000918	CbGpPWpGaD
Bepridil—CALM2—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	0.000107	0.000914	CbGpPWpGaD
Bepridil—CALM1—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	0.000107	0.000914	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—CTGF—systemic scleroderma	0.000106	0.000911	CbGpPWpGaD
Bepridil—CACNA1D—Developmental Biology—MMP9—systemic scleroderma	0.000106	0.00091	CbGpPWpGaD
Bepridil—CALM3—Disease—SMAD7—systemic scleroderma	0.000101	0.000867	CbGpPWpGaD
Bepridil—CALM1—Disease—SMAD7—systemic scleroderma	9.78e-05	0.000839	CbGpPWpGaD
Bepridil—CALM2—Disease—SMAD7—systemic scleroderma	9.78e-05	0.000839	CbGpPWpGaD
Bepridil—CACNA1A—Metabolism—NOS3—systemic scleroderma	9.67e-05	0.00083	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—MMP9—systemic scleroderma	9.32e-05	0.0008	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—RHOB—systemic scleroderma	9.27e-05	0.000795	CbGpPWpGaD
Bepridil—CALM3—Disease—TGFBI—systemic scleroderma	9.24e-05	0.000793	CbGpPWpGaD
Bepridil—PDE1A—Hemostasis—TGFB1—systemic scleroderma	9.16e-05	0.000786	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CTLA4—systemic scleroderma	9.06e-05	0.000777	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—RHOB—systemic scleroderma	8.96e-05	0.000769	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—RHOB—systemic scleroderma	8.96e-05	0.000769	CbGpPWpGaD
Bepridil—CALM1—Disease—TGFBI—systemic scleroderma	8.94e-05	0.000767	CbGpPWpGaD
Bepridil—CALM2—Disease—TGFBI—systemic scleroderma	8.94e-05	0.000767	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—CCL2—systemic scleroderma	8.92e-05	0.000765	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CTLA4—systemic scleroderma	8.76e-05	0.000752	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CTLA4—systemic scleroderma	8.76e-05	0.000752	CbGpPWpGaD
Bepridil—CACNA1D—Developmental Biology—TGFB1—systemic scleroderma	8.74e-05	0.00075	CbGpPWpGaD
Bepridil—PDE1B—Hemostasis—TGFB1—systemic scleroderma	8.38e-05	0.000719	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—CCL2—systemic scleroderma	8.16e-05	0.0007	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—NOS3—systemic scleroderma	8.1e-05	0.000695	CbGpPWpGaD
Bepridil—CALM3—Immune System—CSK—systemic scleroderma	7.71e-05	0.000662	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—EDN1—systemic scleroderma	7.71e-05	0.000661	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—TGFB1—systemic scleroderma	7.68e-05	0.000659	CbGpPWpGaD
Bepridil—CALM3—Immune System—IRF5—systemic scleroderma	7.59e-05	0.000651	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HLA-DQB1—systemic scleroderma	7.46e-05	0.00064	CbGpPWpGaD
Bepridil—CALM2—Immune System—CSK—systemic scleroderma	7.46e-05	0.00064	CbGpPWpGaD
Bepridil—CALM1—Immune System—CSK—systemic scleroderma	7.46e-05	0.00064	CbGpPWpGaD
Bepridil—CALM3—Disease—HSPG2—systemic scleroderma	7.37e-05	0.000633	CbGpPWpGaD
Bepridil—CALM2—Immune System—IRF5—systemic scleroderma	7.34e-05	0.00063	CbGpPWpGaD
Bepridil—CALM1—Immune System—IRF5—systemic scleroderma	7.34e-05	0.00063	CbGpPWpGaD
Bepridil—CALM3—Immune System—IRF8—systemic scleroderma	7.25e-05	0.000622	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD247—systemic scleroderma	7.25e-05	0.000622	CbGpPWpGaD
Bepridil—CALM3—Immune System—ITGAM—systemic scleroderma	7.25e-05	0.000622	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HLA-DQB1—systemic scleroderma	7.22e-05	0.000619	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HLA-DQB1—systemic scleroderma	7.22e-05	0.000619	CbGpPWpGaD
Bepridil—CALM1—Disease—HSPG2—systemic scleroderma	7.13e-05	0.000612	CbGpPWpGaD
Bepridil—CALM2—Disease—HSPG2—systemic scleroderma	7.13e-05	0.000612	CbGpPWpGaD
Bepridil—CALM3—Disease—CSK—systemic scleroderma	7.12e-05	0.000611	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SMAD7—systemic scleroderma	7.08e-05	0.000607	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—EDN1—systemic scleroderma	7.05e-05	0.000605	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—CD40LG—systemic scleroderma	7.05e-05	0.000605	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD247—systemic scleroderma	7.01e-05	0.000602	CbGpPWpGaD
Bepridil—CALM1—Immune System—IRF8—systemic scleroderma	7.01e-05	0.000602	CbGpPWpGaD
Bepridil—CALM1—Immune System—ITGAM—systemic scleroderma	7.01e-05	0.000602	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD247—systemic scleroderma	7.01e-05	0.000602	CbGpPWpGaD
Bepridil—CALM2—Immune System—ITGAM—systemic scleroderma	7.01e-05	0.000602	CbGpPWpGaD
Bepridil—CALM2—Immune System—IRF8—systemic scleroderma	7.01e-05	0.000602	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—MMP1—systemic scleroderma	6.93e-05	0.000595	CbGpPWpGaD
Bepridil—CALM1—Disease—CSK—systemic scleroderma	6.89e-05	0.000591	CbGpPWpGaD
Bepridil—CALM2—Disease—CSK—systemic scleroderma	6.89e-05	0.000591	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SMAD7—systemic scleroderma	6.85e-05	0.000587	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SMAD7—systemic scleroderma	6.85e-05	0.000587	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—CD40LG—systemic scleroderma	6.82e-05	0.000585	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—CD40LG—systemic scleroderma	6.82e-05	0.000585	CbGpPWpGaD
Bepridil—CALM3—Immune System—TNFAIP3—systemic scleroderma	6.79e-05	0.000583	CbGpPWpGaD
Bepridil—CALM3—Immune System—BLK—systemic scleroderma	6.71e-05	0.000576	CbGpPWpGaD
Bepridil—PDE1A—Disease—NOS3—systemic scleroderma	6.71e-05	0.000576	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—MMP1—systemic scleroderma	6.7e-05	0.000575	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—MMP1—systemic scleroderma	6.7e-05	0.000575	CbGpPWpGaD
Bepridil—CALM3—Disease—CD247—systemic scleroderma	6.69e-05	0.000574	CbGpPWpGaD
Bepridil—CALM2—Immune System—TNFAIP3—systemic scleroderma	6.57e-05	0.000564	CbGpPWpGaD
Bepridil—CALM1—Immune System—TNFAIP3—systemic scleroderma	6.57e-05	0.000564	CbGpPWpGaD
Bepridil—CALM1—Immune System—BLK—systemic scleroderma	6.49e-05	0.000557	CbGpPWpGaD
Bepridil—CALM2—Immune System—BLK—systemic scleroderma	6.49e-05	0.000557	CbGpPWpGaD
Bepridil—CALM1—Disease—CD247—systemic scleroderma	6.48e-05	0.000556	CbGpPWpGaD
Bepridil—CALM2—Disease—CD247—systemic scleroderma	6.48e-05	0.000556	CbGpPWpGaD
Bepridil—CALM3—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	6.44e-05	0.000553	CbGpPWpGaD
Bepridil—CALM2—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	6.23e-05	0.000535	CbGpPWpGaD
Bepridil—CALM1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	6.23e-05	0.000535	CbGpPWpGaD
Bepridil—PDE1A—Immune System—IL1B—systemic scleroderma	6.18e-05	0.00053	CbGpPWpGaD
Bepridil—CALM3—Metabolism—HSPG2—systemic scleroderma	6.17e-05	0.00053	CbGpPWpGaD
Bepridil—PDE1B—Disease—NOS3—systemic scleroderma	6.13e-05	0.000526	CbGpPWpGaD
Bepridil—CALM1—Metabolism—HSPG2—systemic scleroderma	5.97e-05	0.000513	CbGpPWpGaD
Bepridil—CALM2—Metabolism—HSPG2—systemic scleroderma	5.97e-05	0.000513	CbGpPWpGaD
Bepridil—PDE1B—Immune System—IL1B—systemic scleroderma	5.65e-05	0.000485	CbGpPWpGaD
Bepridil—CALM3—Immune System—CTLA4—systemic scleroderma	5.49e-05	0.000472	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	5.49e-05	0.000471	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—RHOB—systemic scleroderma	5.47e-05	0.00047	CbGpPWpGaD
Bepridil—CALM2—Immune System—CTLA4—systemic scleroderma	5.32e-05	0.000456	CbGpPWpGaD
Bepridil—CALM1—Immune System—CTLA4—systemic scleroderma	5.32e-05	0.000456	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—RHOB—systemic scleroderma	5.3e-05	0.000454	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—RHOB—systemic scleroderma	5.3e-05	0.000454	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CCL2—systemic scleroderma	5.27e-05	0.000452	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—NOS3—systemic scleroderma	5.26e-05	0.000451	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HSPG2—systemic scleroderma	5.16e-05	0.000443	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—NOS3—systemic scleroderma	5.02e-05	0.000431	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HSPG2—systemic scleroderma	4.99e-05	0.000429	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HSPG2—systemic scleroderma	4.99e-05	0.000429	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CSK—systemic scleroderma	4.99e-05	0.000428	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—NOS3—systemic scleroderma	4.86e-05	0.000417	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—NOS3—systemic scleroderma	4.86e-05	0.000417	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CSK—systemic scleroderma	4.82e-05	0.000414	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CSK—systemic scleroderma	4.82e-05	0.000414	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CCL2—systemic scleroderma	4.82e-05	0.000414	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EDN1—systemic scleroderma	4.73e-05	0.000406	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—NOS3—systemic scleroderma	4.7e-05	0.000403	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—HSPG2—systemic scleroderma	4.68e-05	0.000402	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CTGF—systemic scleroderma	4.68e-05	0.000402	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—NOS3—systemic scleroderma	4.62e-05	0.000397	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EDN1—systemic scleroderma	4.58e-05	0.000393	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EDN1—systemic scleroderma	4.58e-05	0.000393	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CTGF—systemic scleroderma	4.53e-05	0.000388	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CTGF—systemic scleroderma	4.53e-05	0.000388	CbGpPWpGaD
Bepridil—CALM3—Immune System—HLA-DQB1—systemic scleroderma	4.53e-05	0.000388	CbGpPWpGaD
Bepridil—PDE1A—Disease—TGFB1—systemic scleroderma	4.43e-05	0.000381	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—HSPG2—systemic scleroderma	4.41e-05	0.000378	CbGpPWpGaD
Bepridil—CALM2—Immune System—HLA-DQB1—systemic scleroderma	4.38e-05	0.000376	CbGpPWpGaD
Bepridil—CALM1—Immune System—HLA-DQB1—systemic scleroderma	4.38e-05	0.000376	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL1A—systemic scleroderma	4.3e-05	0.000369	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—NOS3—systemic scleroderma	4.3e-05	0.000369	CbGpPWpGaD
Bepridil—CALM3—Immune System—CD40LG—systemic scleroderma	4.27e-05	0.000367	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL1A—systemic scleroderma	4.16e-05	0.000357	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL1A—systemic scleroderma	4.16e-05	0.000357	CbGpPWpGaD
Bepridil—CALM2—Immune System—CD40LG—systemic scleroderma	4.13e-05	0.000355	CbGpPWpGaD
Bepridil—CALM1—Immune System—CD40LG—systemic scleroderma	4.13e-05	0.000355	CbGpPWpGaD
Bepridil—PDE1B—Disease—TGFB1—systemic scleroderma	4.06e-05	0.000348	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—MMP9—systemic scleroderma	3.77e-05	0.000323	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CTGF—systemic scleroderma	3.55e-05	0.000304	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—MMP9—systemic scleroderma	3.45e-05	0.000296	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CTGF—systemic scleroderma	3.34e-05	0.000287	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TGFB1—systemic scleroderma	3.32e-05	0.000285	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CCL2—systemic scleroderma	3.23e-05	0.000278	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TGFB1—systemic scleroderma	3.21e-05	0.000276	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TGFB1—systemic scleroderma	3.21e-05	0.000276	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CCL2—systemic scleroderma	3.13e-05	0.000269	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CCL2—systemic scleroderma	3.13e-05	0.000269	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TGFB1—systemic scleroderma	3.11e-05	0.000266	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TGFB1—systemic scleroderma	2.84e-05	0.000244	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EDN1—systemic scleroderma	2.8e-05	0.00024	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EDN1—systemic scleroderma	2.7e-05	0.000232	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EDN1—systemic scleroderma	2.7e-05	0.000232	CbGpPWpGaD
Bepridil—CALM3—Disease—NOS3—systemic scleroderma	2.43e-05	0.000209	CbGpPWpGaD
Bepridil—CALM1—Disease—NOS3—systemic scleroderma	2.35e-05	0.000202	CbGpPWpGaD
Bepridil—CALM2—Disease—NOS3—systemic scleroderma	2.35e-05	0.000202	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL1B—systemic scleroderma	2.24e-05	0.000192	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL1B—systemic scleroderma	2.17e-05	0.000186	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL1B—systemic scleroderma	2.17e-05	0.000186	CbGpPWpGaD
Bepridil—CALM3—Metabolism—NOS3—systemic scleroderma	2.04e-05	0.000175	CbGpPWpGaD
Bepridil—CALM2—Metabolism—NOS3—systemic scleroderma	1.97e-05	0.000169	CbGpPWpGaD
Bepridil—CALM1—Metabolism—NOS3—systemic scleroderma	1.97e-05	0.000169	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCL2—systemic scleroderma	1.91e-05	0.000164	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCL2—systemic scleroderma	1.85e-05	0.000159	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCL2—systemic scleroderma	1.85e-05	0.000159	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NOS3—systemic scleroderma	1.7e-05	0.000146	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NOS3—systemic scleroderma	1.65e-05	0.000141	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NOS3—systemic scleroderma	1.65e-05	0.000141	CbGpPWpGaD
Bepridil—CALM3—Disease—TGFB1—systemic scleroderma	1.61e-05	0.000138	CbGpPWpGaD
Bepridil—CALM2—Disease—TGFB1—systemic scleroderma	1.56e-05	0.000133	CbGpPWpGaD
Bepridil—CALM1—Disease—TGFB1—systemic scleroderma	1.56e-05	0.000133	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—NOS3—systemic scleroderma	1.54e-05	0.000132	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—NOS3—systemic scleroderma	1.45e-05	0.000125	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MMP9—systemic scleroderma	1.37e-05	0.000117	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MMP9—systemic scleroderma	1.32e-05	0.000113	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MMP9—systemic scleroderma	1.32e-05	0.000113	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TGFB1—systemic scleroderma	1.13e-05	9.66e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TGFB1—systemic scleroderma	1.09e-05	9.35e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TGFB1—systemic scleroderma	1.09e-05	9.35e-05	CbGpPWpGaD
